Enanta Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
436.7 | 48.77 | 795.42% | 171.57 | +154.53% |
| P/S |
|
2.94 | 33.76 | -91.3% |
|
|
| P/BV |
|
1.07 | 4.82 | -77.74% |
|
|
| P/FCF |
|
-2.93 | 60.98 | -104.8% |
|
|
| Ev/Ebitda |
|
-1.41 | -22.31 | -93.7% |
|
|
| Ev/S |
|
2.19 | 22.56 | -90.28% |
|
|
| Ev/FCF |
|
-1.55 | 68.75 | -102.25% |
|
|
| E/P |
|
-0.4071 | 0.0178 | -2390.46% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-155.9 | 5.1 | -3156.53% | -79.63 | +95.79% |
| ROE |
|
-61.74 | 9.61 | -742.73% |
|
|
| ROA |
|
-28.95 | 0.3359 | -8717.68% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-168.95 | -25.17 | 571.23% |
|
|
| ROCE |
|
-58.06 | 15.48 | -475.18% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2147 | -3.69 | -94.18% | -0.2031 | +5.71% |
| Nеt Debt/Ebitda |
|
0.4768 | -3.44 | -113.85% |
|
|
| Debt/Ratio |
|
0.0574 | 0.1972 | -70.91% |
|
|
| Debt/Equity |
|
0.8927 | 1.65 | -45.78% |
|
|
| Debt/Net Income |
|
-0.1981 | 10.31 | -101.92% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5499 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% | ||
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0635 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.494 | -100% |
|
|
| Average percentage for payments |
|
5.73 | 43.56 | -86.84% |
|
|
| Difference from average difference in sector |
|
-0.5499 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-61.4 | -56.89 | 7.93% | ||
| Growth impulse Ebitda in 5 years |
|
-352.95 | -53.14 | 564.19% | ||
| Growth impulse Net Income in 5 years |
|
-388.5 | -58.33 | 566.04% | ||
| Growth impulse FCF in 5 years |
|
-270.02 | -47 | 474.51% | ||
| Growth impulse EPS in 5 years |
|
-388.49 | -32.41 | 1098.67% |
IP Score
3.14/10
